These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24527460)

  • 1. Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?
    Paldino E; Tesori V; Casalbore P; Gasbarrini A; Puglisi MA
    Biomed Res Int; 2014; 2014():859871. PubMed ID: 24527460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular identification and targeting of colorectal cancer stem cells.
    Kemper K; Grandela C; Medema JP
    Oncotarget; 2010 Oct; 1(6):387-395. PubMed ID: 21311095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.
    Planque C; Rajabi F; Grillet F; Finetti P; Bertucci F; Gironella M; Lozano JJ; Beucher B; Giraud J; Garambois V; Vincent C; Brown D; Caillo L; Kantar J; Pelegrin A; Prudhomme M; Ripoche J; Bourgaux JF; Ginestier C; Castells A; Hollande F; Pannequin J; Pascussi JM
    Oncotarget; 2016 Aug; 7(35):56558-56573. PubMed ID: 27448961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
    Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells and Chemoresistance in Ewing Sarcoma.
    Dos Santos RP; Roesler R; Gregianin L; Brunetto AT; da Cunha Jaeger M; Lunardi Brunetto A; de Farias CB
    Curr Stem Cell Res Ther; 2023; 18(7):926-936. PubMed ID: 35761483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.
    Ke J; Wu X; Wu X; He X; Lian L; Zou Y; He X; Wang H; Luo Y; Wang L; Lan P
    Neoplasma; 2012; 59(3):282-8. PubMed ID: 22329848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
    Malhi S; Gu X
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling Warburg effect and stemness in CD133
    Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
    Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
    Hyun SY; Le HT; Min HY; Pei H; Lim Y; Song I; Nguyen YTK; Hong S; Han BW; Lee HY
    Theranostics; 2021; 11(6):2932-2952. PubMed ID: 33456581
    [No Abstract]   [Full Text] [Related]  

  • 17. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
    Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
    Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells in prostate cancer chemoresistance.
    Ni J; Cozzi P; Hao J; Duan W; Graham P; Kearsley J; Li Y
    Curr Cancer Drug Targets; 2014; 14(3):225-40. PubMed ID: 24720286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
    Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
    Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.